Move Over Mammo

July 19, 2012

Move Over Mammo

As the number and type of breast imaging modalities have multiplied and research has demonstrated their effectiveness, it may be time for women's imaging practices to consider the role of new technologies in breast cancer screening and detection.

In the last 18 months, regulatory, technical and legislative developments have occurred at a head-spinning pace. The FDA approved tomosynthesis, and an FDA advisory panel recommended approval of automated ultrasound as an adjunct to mammography for women with dense breasts.